SCHEDULE 13G
Statement of Beneficial Ownership
Avalo Therapeutics, Inc. Filed Acc 0000935836-26-000188
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…